Gold jumped to two-week high of $1237.94 in Asia on broad based USD selling.
Nears trend line hurdle
The trend line sloping upwards from Jan 27 low and Mar 10 low is seen offering resistance around $1240 levels. The metal was last seen trading around the session highs and looked set to test supply around the trend line resistance.
The bullish move gathered pace after the news hit the wires that Trump's care bill has been rejected yet again by Republicans. The health care affair was largely seen as test of Trump’s legislative ability. The failure here means the task of pushing through tax reforms would be even more difficult.
Consequently, the greenback has been offered across the board. The Dollar Index dropped to 84.74; the lowest level since September 2016.
Gold Technical Levels
A break above the trend line hurdle of $124 would open doors for resistance at $1247 (100-DMA) and $12583.90 (June 23 high). On the downside, breach of support at $1232.50 (session low) could yield a re-test of $1229.59 (200-DMA). An end of the day close below the 200-DMA would signal the corrective rally has ended, in which case the support at $1217.63 (July 5) could be put to test again.
|TREND INDEX||OB/OS INDEX||VOLATILY INDEX|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.